Important drug interactions in patients with rheumatic disorders: interactions of glucocorticoids, immunosuppressants and antimalarial drugs

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10124575" target="_blank" >RIV/00179906:_____/12:10124575 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/12:10124575 RIV/00216208:11160/12:10124575

Výsledek na webu

<a href="http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=1841300" target="_blank" >http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=1841300</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1358/dot.2012.48.8.1841300" target="_blank" >10.1358/dot.2012.48.8.1841300</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Important drug interactions in patients with rheumatic disorders: interactions of glucocorticoids, immunosuppressants and antimalarial drugs

Popis výsledku v původním jazyce

Despite the fact that biological treatments are very promising, classical immunosuppressants, antimalarial drugs and glucocorticosteroids are still very important and widely used in practice. Although drug interactions can have fatal consequences, few studies have reviewed drug interactions of these classical drugs used in rheumatology, and very few guidelines are available on this subject. Therefore, this report summarizes important interactions of immunosuppressants, antimalarial drugs and glucocorticosteroids with drugs commonly used in internal medicine. In the present study, more than 300 interactions were retrieved from the Micromedex (R) database. The selection was reduced to the interactions rated as moderate, major or contraindicated. The selected interactions were further checked against PubMed (R), MEDLINE (R), InfoPharm Compendium of Drug Interactions and Summaries of Product Characteristics. For each interaction, its nature, mechanism, onset and clinical severity were indi

Název v anglickém jazyce

Important drug interactions in patients with rheumatic disorders: interactions of glucocorticoids, immunosuppressants and antimalarial drugs

Popis výsledku anglicky

Despite the fact that biological treatments are very promising, classical immunosuppressants, antimalarial drugs and glucocorticosteroids are still very important and widely used in practice. Although drug interactions can have fatal consequences, few studies have reviewed drug interactions of these classical drugs used in rheumatology, and very few guidelines are available on this subject. Therefore, this report summarizes important interactions of immunosuppressants, antimalarial drugs and glucocorticosteroids with drugs commonly used in internal medicine. In the present study, more than 300 interactions were retrieved from the Micromedex (R) database. The selection was reduced to the interactions rated as moderate, major or contraindicated. The selected interactions were further checked against PubMed (R), MEDLINE (R), InfoPharm Compendium of Drug Interactions and Summaries of Product Characteristics. For each interaction, its nature, mechanism, onset and clinical severity were indi

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FR - Farmakologie a lékárnická chemie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Drugs of Today

ISSN

1699-3993

e-ISSN

—

Svazek periodika

48

Číslo periodika v rámci svazku

8

Stát vydavatele periodika

ES - Španělské království

Počet stran výsledku

9

Strana od-do

545-553

Kód UT WoS článku

000309983600005

EID výsledku v databázi Scopus

—